Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Effectiveness of CoronaVac in the setting of high SARS-CoV-2 P.1 variant transmission in Brazil: A test-negative case-control study

Matt D.T. Hitchings, Otavio T. Ranzani, Mario Sergio Scaramuzzini Torres, Silvano Barbosa de Oliveira, Maria Almiron, Rodrigo Said, Ryan Borg, Wade L. Schulz, Roberto Dias de Oliveira, Patricia Vieira da Silva, Daniel Barros de Castro, Vanderson de Souza Sampaio, Bernardino Cláudio de Albuquerque, Tatyana Costa Amorim Ramos, Shadia Hussami Hauache Fraxe, Cristiano Fernandes da Costa, Felipe Gomes Naveca, Andre M. Siqueira, Wildo Navegantes de Araújo, Jason R. Andrews, Derek A.T. Cummings, Albert I. Ko, Julio Croda
doi: https://doi.org/10.1101/2021.04.07.21255081
Matt D.T. Hitchings
1Department of Biology, University of Florida, Gainesville, FL, USA
2Emerging Pathogens Institute, University of Florida, Gainesville, FL, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Otavio T. Ranzani
3Universidade de Sao Paulo, São Paulo, SP, Brazil
4Barcelona Institute for Global Health, ISGlobal, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mario Sergio Scaramuzzini Torres
5Municipal Health Secretary of Manaus
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Silvano Barbosa de Oliveira
6Pan American Health Organization
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria Almiron
6Pan American Health Organization
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rodrigo Said
6Pan American Health Organization
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ryan Borg
7Universidade de Brasília, Brasília, DF, Brazil
8Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wade L. Schulz
9Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, CT, USA
10Department of Laboratory Medicine, Yale University School of Medicine, New Haven, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roberto Dias de Oliveira
11State University of Mato Grosso do Sul - UEMS, Dourados, MS, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patricia Vieira da Silva
12Universidade Federal de Mato Grosso do Sul - UFMS, Campo Grande, MS, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel Barros de Castro
13Fundação de Vigilância em Saúde do Estado do Amazonas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vanderson de Souza Sampaio
13Fundação de Vigilância em Saúde do Estado do Amazonas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bernardino Cláudio de Albuquerque
13Fundação de Vigilância em Saúde do Estado do Amazonas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tatyana Costa Amorim Ramos
13Fundação de Vigilância em Saúde do Estado do Amazonas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shadia Hussami Hauache Fraxe
15Division of Infectious Diseases and Geographic Medicine, Stanford University, Stanford, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cristiano Fernandes da Costa
13Fundação de Vigilância em Saúde do Estado do Amazonas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Felipe Gomes Naveca
17Fiocruz Mato Grosso do Sul, Fundação Oswaldo Cruz, Campo Grande, MS, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andre M. Siqueira
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wildo Navegantes de Araújo
14Pulmonary Division, Heart Institute (InCor), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, National Institute for Science and Technology for Health Technology Assessment, Porto Alegre, RS, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jason R. Andrews
15Division of Infectious Diseases and Geographic Medicine, Stanford University, Stanford, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Derek A.T. Cummings
1Department of Biology, University of Florida, Gainesville, FL, USA
2Emerging Pathogens Institute, University of Florida, Gainesville, FL, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Albert I. Ko
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julio Croda
9Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, CT, USA
12Universidade Federal de Mato Grosso do Sul - UFMS, Campo Grande, MS, Brazil
17Fiocruz Mato Grosso do Sul, Fundação Oswaldo Cruz, Campo Grande, MS, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: julio.croda@fiocruz.br
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant P.1 emerged in the city of Manaus in late 2020 during a large resurgence of coronavirus disease (COVID-19), and has spread throughout Brazil. The effectiveness of vaccines in settings with widespread P.1 transmission has not been reported.

Methods We performed a matched test-negative case-control study to estimate the effectiveness of an inactivated vaccine, CoronaVac, in healthcare workers (HCWs) in Manaus, where P.1 accounted for 75% of genotyped SARS-CoV-2 samples at the peak of its epidemic. Information from electronic surveillance databases was used to select cases of RT-PCR-confirmed SARS-CoV-2 infection and matched test-negative controls from 19 January, 2021 to 25 March, 2021. We used conditional logistic regression to estimate the effectiveness in reducing the odds of primary and secondary outcomes of, respectively, symptomatic and any SARS-CoV-2 infection.

Findings Among 53,176 HCWs, 46,884 (88%) received at least one dose of CoronaVac and 2,656 (5%) underwent RT-PCR testing from 19 January, 2021 to 25 March, 2021. Of 2,797 RT-PCR tests, 776 (28%) were positive. 393 and 135 case-control pairs with and without, respectively, symptomatic illness were selected for the matched analyses. Vaccination with at least one dose was associated with a 0.50-fold reduction (adjusted vaccine effectiveness, 49.6%; 95% CI, 11.3 - 71.4) in the odds of symptomatic SARS-CoV-2 infection during the period 14 days or more after receiving the first dose. Estimated vaccine effectiveness of at least one dose against any SARS-CoV-2 infection was 35.1% (95% CI, −6.6 - 60.5) in the same time period.

Interpretation Administration of at least one dose of CoronaVac showed effectiveness against symptomatic SARS-CoV-2 infection in the setting of epidemic P.1 transmission, underscoring the need to increase vaccination efforts in response to the spread of this variant in Brazil and globally.

Funding Pan American Health Organization; Fundação Oswaldo Cruz (Fiocruz); Municipal Health Secretary of Manaus

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

We are grateful for Pan American Health Organization’s support to the Fundação Vigilância em Saúde from Amazonas State and the Municipal Health Secretary of Manaus in making the databases available for analysis. JC and AS are supported by the Oswaldo Cruz Foundation (Edital Covid-19 - resposta rápida: 48111668950485). OTR is funded by a Sara Borrell fellowship (CD19/00110) from the Instituto de Salud Carlos III. OTR acknowledges support from the Spanish Ministry of Science and Innovation through the Centro de Excelencia Severo Ochoa 2019-2023 Program and from the Generalitat de Catalunya through the CERCA Program.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study was approved by the Ethical Committee for Research of Federal University of Mato Grosso do Sul (CAAE: 43289221.5.0000.0021).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Deidentified databases as well as the R codes will be deposited in the repository https://github.com/juliocroda/VebraCOVID-19

https://github.com/juliocroda/VebraCOVID-19

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Back to top
PreviousNext
Posted April 07, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Effectiveness of CoronaVac in the setting of high SARS-CoV-2 P.1 variant transmission in Brazil: A test-negative case-control study
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Effectiveness of CoronaVac in the setting of high SARS-CoV-2 P.1 variant transmission in Brazil: A test-negative case-control study
Matt D.T. Hitchings, Otavio T. Ranzani, Mario Sergio Scaramuzzini Torres, Silvano Barbosa de Oliveira, Maria Almiron, Rodrigo Said, Ryan Borg, Wade L. Schulz, Roberto Dias de Oliveira, Patricia Vieira da Silva, Daniel Barros de Castro, Vanderson de Souza Sampaio, Bernardino Cláudio de Albuquerque, Tatyana Costa Amorim Ramos, Shadia Hussami Hauache Fraxe, Cristiano Fernandes da Costa, Felipe Gomes Naveca, Andre M. Siqueira, Wildo Navegantes de Araújo, Jason R. Andrews, Derek A.T. Cummings, Albert I. Ko, Julio Croda
medRxiv 2021.04.07.21255081; doi: https://doi.org/10.1101/2021.04.07.21255081
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Effectiveness of CoronaVac in the setting of high SARS-CoV-2 P.1 variant transmission in Brazil: A test-negative case-control study
Matt D.T. Hitchings, Otavio T. Ranzani, Mario Sergio Scaramuzzini Torres, Silvano Barbosa de Oliveira, Maria Almiron, Rodrigo Said, Ryan Borg, Wade L. Schulz, Roberto Dias de Oliveira, Patricia Vieira da Silva, Daniel Barros de Castro, Vanderson de Souza Sampaio, Bernardino Cláudio de Albuquerque, Tatyana Costa Amorim Ramos, Shadia Hussami Hauache Fraxe, Cristiano Fernandes da Costa, Felipe Gomes Naveca, Andre M. Siqueira, Wildo Navegantes de Araújo, Jason R. Andrews, Derek A.T. Cummings, Albert I. Ko, Julio Croda
medRxiv 2021.04.07.21255081; doi: https://doi.org/10.1101/2021.04.07.21255081

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (76)
  • Allergy and Immunology (202)
  • Anesthesia (55)
  • Cardiovascular Medicine (497)
  • Dentistry and Oral Medicine (91)
  • Dermatology (57)
  • Emergency Medicine (170)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (220)
  • Epidemiology (5776)
  • Forensic Medicine (3)
  • Gastroenterology (223)
  • Genetic and Genomic Medicine (889)
  • Geriatric Medicine (89)
  • Health Economics (235)
  • Health Informatics (778)
  • Health Policy (401)
  • Health Systems and Quality Improvement (259)
  • Hematology (108)
  • HIV/AIDS (188)
  • Infectious Diseases (except HIV/AIDS) (6612)
  • Intensive Care and Critical Care Medicine (398)
  • Medical Education (120)
  • Medical Ethics (29)
  • Nephrology (94)
  • Neurology (864)
  • Nursing (46)
  • Nutrition (145)
  • Obstetrics and Gynecology (166)
  • Occupational and Environmental Health (268)
  • Oncology (521)
  • Ophthalmology (169)
  • Orthopedics (44)
  • Otolaryngology (108)
  • Pain Medicine (49)
  • Palliative Medicine (22)
  • Pathology (150)
  • Pediatrics (258)
  • Pharmacology and Therapeutics (147)
  • Primary Care Research (116)
  • Psychiatry and Clinical Psychology (998)
  • Public and Global Health (2273)
  • Radiology and Imaging (382)
  • Rehabilitation Medicine and Physical Therapy (176)
  • Respiratory Medicine (315)
  • Rheumatology (111)
  • Sexual and Reproductive Health (85)
  • Sports Medicine (83)
  • Surgery (118)
  • Toxicology (25)
  • Transplantation (35)
  • Urology (42)